Headquartered in San Francisco and co-founded by Musk in 2016, Neuralink aims to implant computer chips into the human brain to help treat neurological diseases such as Alzheimer’s, dementia and spinal cord injury, and to compare humans with artificial Intelligence (AI) comes together.
Musk said in a 2019 presentation that Neuralink aims to gain regulatory approval by the end of 2020 to conduct experiments with chips implanted in the human brain. So far, though, the company has not received such approval and has yet to bring a product to market.
Neuralink is also showing the technology in pigs and monkeys in demonstrations in 2020 and 2021. Musk said the technique worked well in monkeys, and he hopes to apply it to the first humans, such as quadriplegics, this year.
Musk has approached brain chip implant developer Synchron about a potential investment. He had previously expressed his disappointment to Neuralink employees, citing the company’s slow progress in gaining regulatory approval.